DaVita HealthCare Partners Inc. (NYSE:DVA) received a $57.00 target price from equities research analysts at SunTrust Banks, Inc. in a research report issued to clients and investors on Sunday. The firm presently has a “hold” rating on the stock. SunTrust Banks, Inc.’s price target points to a potential upside of 4.15% from the stock’s previous close.
DVA has been the subject of a number of other research reports. BidaskClub lowered DaVita HealthCare Partners from a “sell” rating to a “strong sell” rating in a research report on Saturday, August 5th. Jefferies Group LLC lowered DaVita HealthCare Partners from a “buy” rating to a “hold” rating and increased their price target for the company from $64.89 to $70.00 in a research report on Monday, June 26th. Zacks Investment Research lowered DaVita HealthCare Partners from a “hold” rating to a “sell” rating in a research report on Tuesday, July 4th. J P Morgan Chase & Co lowered DaVita HealthCare Partners from a “neutral” rating to an “underweight” rating in a research report on Monday, October 9th. Finally, Royal Bank Of Canada reiterated a “hold” rating and issued a $64.00 price target on shares of DaVita HealthCare Partners in a research report on Wednesday, September 6th. Four equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and one has assigned a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $65.00.
DaVita HealthCare Partners (NYSE DVA) opened at 54.73 on Friday. DaVita HealthCare Partners has a 52 week low of $53.58 and a 52 week high of $70.16. The company has a 50-day moving average of $58.31 and a 200 day moving average of $62.84. The firm has a market cap of $10.46 billion, a P/E ratio of 8.34 and a beta of 0.90.
DaVita HealthCare Partners (NYSE:DVA) last announced its earnings results on Tuesday, August 1st. The company reported $0.92 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.90 by $0.02. DaVita HealthCare Partners had a return on equity of 14.02% and a net margin of 8.68%. The business had revenue of $3.88 billion during the quarter, compared to analysts’ expectations of $3.82 billion. During the same quarter last year, the business posted $1.01 earnings per share. The company’s quarterly revenue was up 4.3% on a year-over-year basis. On average, equities analysts predict that DaVita HealthCare Partners will post $3.59 earnings per share for the current year.
DaVita HealthCare Partners announced that its board has initiated a share buyback plan on Tuesday, October 10th that allows the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization allows the company to reacquire shares of its stock through open market purchases. Shares repurchase plans are often a sign that the company’s leadership believes its stock is undervalued.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Riverhead Capital Management LLC grew its holdings in shares of DaVita HealthCare Partners by 10.6% during the 2nd quarter. Riverhead Capital Management LLC now owns 112,506 shares of the company’s stock worth $7,286,000 after purchasing an additional 10,775 shares in the last quarter. Eqis Capital Management Inc. lifted its position in shares of DaVita HealthCare Partners by 2.2% during the 2nd quarter. Eqis Capital Management Inc. now owns 4,600 shares of the company’s stock worth $298,000 after buying an additional 100 shares during the period. Accident Compensation Corp lifted its position in shares of DaVita HealthCare Partners by 147.5% during the 2nd quarter. Accident Compensation Corp now owns 15,100 shares of the company’s stock worth $978,000 after buying an additional 9,000 shares during the period. Founders Capital Management LLC lifted its position in shares of DaVita HealthCare Partners by 0.6% during the 2nd quarter. Founders Capital Management LLC now owns 93,824 shares of the company’s stock worth $6,076,000 after buying an additional 520 shares during the period. Finally, Jensen Investment Management Inc. lifted its position in shares of DaVita HealthCare Partners by 24.2% during the 2nd quarter. Jensen Investment Management Inc. now owns 9,740 shares of the company’s stock worth $631,000 after buying an additional 1,900 shares during the period. 83.23% of the stock is currently owned by hedge funds and other institutional investors.
About DaVita HealthCare Partners
DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.
Receive News & Ratings for DaVita HealthCare Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.